LANZATECH GLOBAL INC (LNZA) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:LNZA • US51655R2004

9.7689 USD
-0.05 (-0.52%)
Last: Feb 6, 2026, 12:30 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to LNZA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 134.64. This target is 1278.25% above the current price.
  • LNZA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about LNZA.
  • In the previous month the buy percentage consensus was at a similar level.
  • LNZA was analyzed by 6 analysts. More opinions would make the average more meaningful.
LNZA Historical Analyst RatingsLNZA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -31 -28 -25 -22 -19 -16 -13 -10 -7 -4 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 9.7714.14134.64134.64262.50 - 44.75% 1,278.25% 1,278.25% 2,587.10%
LNZA Current Analyst RatingLNZA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2025-11-20 Roth Capital Maintains Neutral -> Neutral
2025-03-13 Janney Montgomery Scott Downgrade Buy -> Neutral
2024-11-11 TD Cowen Maintains Hold -> Hold
2024-05-07 TD Cowen Initiate Hold
2024-03-25 Roth MKM Maintains Buy -> Buy
2024-03-15 Seaport Global Initiate Buy
2023-12-28 Janney Montgomery Scott Initiate Buy
2023-09-19 Roth MKM Reiterate Buy -> Buy
2023-05-12 Roth MKM Initiate Buy

LANZATECH GLOBAL INC / LNZA FAQ

What is the average price target for LANZATECH GLOBAL INC (LNZA) stock?

6 analysts have analysed LNZA and the average price target is 134.64 USD. This implies a price increase of 1278.25% is expected in the next year compared to the current price of 9.7689.


What is the consensus rating for LNZA stock?

The consensus rating for LANZATECH GLOBAL INC (LNZA) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.